-
Mashup Score: 0Integrated DNA and RNA Sequencing of Advanced Urothelial Cancers - Expert Commentary - 1 year(s) ago
Urothelial Cancer, Genomic Analysis to Improve Patient Outcomes and Research (UC-GENOME) study, Bladder Cancer Advocacy Network (BCAN), bladder cancer, genomics, metastatic urothelial carcinoma, immune checkpoint inhibitors (ICIs), DNA sequencing, RNA sequencing, Basal/squamous, stroma-rich tumors, ERCC2 mutations, FANCC mutations, chromatin-modifying genes.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Jeanny B. Aragon-Ching, MD, FACP, describes the available treatment options for patients with metastatic UC who progress on avelumab maintenance.
Source: GU Oncology NowCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Jeanny B. Aragon-Ching, MD, FACP, Clinical Program Director of Genitourinary Cancers at @InovaSchar, describes available treatment options for locally advanced or metastatic #urothelial carcinoma who progress on #avelumab maintenance. Watch here: https://t.co/k2TmKeU73g https://t.co/qbjdRXejUp
-
-
Mashup Score: 2Integrated DNA and RNA Sequencing of Advanced Urothelial Cancers - Expert Commentary - 1 year(s) ago
Urothelial Cancer, Genomic Analysis to Improve Patient Outcomes and Research (UC-GENOME) study, Bladder Cancer Advocacy Network (BCAN), bladder cancer, genomics, metastatic urothelial carcinoma, immune checkpoint inhibitors (ICIs), DNA sequencing, RNA sequencing, Basal/squamous, stroma-rich tumors, ERCC2 mutations, FANCC mutations, chromatin-modifying genes.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Integrated DNA and RNA sequencing of advanced #Urothelial cancers. #ExpertCommentary @FaltasLab @WCMEnglanderIPM discusses The Urothelial Cancer – Genomic Analysis to Improve Patient Outcomes and Research (UC-GENOME) study. #ReadNow > https://t.co/uWVN7zzrl3 @BladderCancerUS https://t.co/mISvSb53SM
-
-
Mashup Score: 0NECTIN-4 Expression Often Decreases During UC Metastases - 1 year(s) ago
A study found that membranous NECTIN-4 expression is frequently decreased or absent altogether in metastatic urothelial carcinoma tissue.
Source: GU Oncology NowCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
What happens to NECTIN-4 expression during #urothelial carcinoma metastases? Recent findings show that it correlates with #enfortumab vedotin resistance. Learn more: https://t.co/6sebowTac9 https://t.co/VlZ9EyGuRl
-
-
Mashup Score: 0
Two drugs for the treatment of metastatic urothelial carcinoma—eftilagimod alpha and avelumab—will be examined in the phase 1 INSIGHT-005 clinical trial.
Source: GU Oncology NowCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The upcoming phase 1 INSIGHT-005 #clinicaltrial will examine the efficacy of the combination treatment #eftilagimod alpha and #avelumab for metastatic #urothelial carcinoma. Learn more: https://t.co/UsdQpqMQP6 https://t.co/xMeMM4Dobd
-
-
Mashup Score: 0
Enfortumbab vedotin plus pembrolizumab in cisplatin-ineligible patients
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Why do #cisplatin-ineligible patients with advanced or metastatic #urothelial cancer need better first-line treatment options? #oncology @ASCO #ASCOReadingRoom Read more: https://t.co/T8RLOpmgrX https://t.co/u6hBdd5cse
-
-
Mashup Score: 0Above The Fold in Healthcare - 2 year(s) ago
The Front Page of Healthcare News on the Internet by C. Michael Gibson MD
Source: paper.liCategories: Expert Picks, Latest HeadlinesTweet-
The latest Above The Fold in Healthcare! https://t.co/gFLkJHDNkv Thanks to @pharmalot @Reuters_Health #podcast #urothelial
-
-
Mashup Score: 0
As options grow, clinicians must help patients understand and weigh benefits vs risks
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
There are currently three FDA-approved adjuvant therapies for #renal or #urothelial carcinoma. Are any new approvals likely in the next few years? What's in the pipeline? #oncology @ASCO #ASCOReadingRoom Read more: https://t.co/93R9CLxQOH https://t.co/V1Wljp8b7J
-
-
Mashup Score: 0
Tele-health and educational strategies improve care in rural areas
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
One solution to geographic disparities in #urothelial cancer treatment that you suggest is tele-cystoscopy. How does this work, and how does it compare to traditional #cystoscopy in terms of accuracy? #oncology @ASCO #ASCOReadingRoom Read more: https://t.co/lqXCLZC0vm https://t.co/SVGswW32Ym
-
-
Mashup Score: 0
Joining Alicia Morgans is Scott Tagawa to review this year’s GU ASCO 2022 highlights in prostate cancer and urothelial cancer. Dr. Tagawa highlights multiple presentations including the phase 1/2 study of ARV-110, The Phase 1 results of the ODM-208 first-in-human phase 1-2 trial in patients with metastatic castration-resistant prostate cancer (CYPIDES), the VISION Phase 3 Trial, TROPHY-U-01…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Highlights from #urothelial and #prostate #cancer #GU22 @ASCO. @DrScottTagawa @WeillCornell joins @CaPsurvivorship @DanaFarber highlighting multiple presentations from this year's annual meeting > https://t.co/mxHVvorxyx @nyphospital #CYPIDES #VISION #TROPHYU01 #EV103 https://t.co/BW4Edvqisj
-
Integrated DNA and RNA sequencing of advanced #Urothelial cancers. #ExpertCommentary @FaltasLab @WCMEnglanderIPM discusses The Urothelial Cancer – Genomic Analysis to Improve Patient Outcomes and Research (UC-GENOME) study. #ReadNow > https://t.co/uWVN7zzrl3 @BladderCancerUS https://t.co/jN53TE8gfb